BIO-key International, Inc.
BKYI
$0.746
$0.0060.81%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.58% | 9.91% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.58% | 9.91% | |||
| Cost of Revenue | 66.08% | 6.52% | |||
| Gross Profit | -7.16% | 10.65% | |||
| SG&A Expenses | 22.45% | -25.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 23.71% | -17.66% | |||
| Operating Income | -69.20% | 49.46% | |||
| Income Before Tax | -58.51% | 47.67% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -58.51% | 46.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -58.51% | 46.80% | |||
| EBIT | -69.20% | 49.46% | |||
| EBITDA | -81.24% | 53.70% | |||
| EPS Basic | -28.03% | 65.70% | |||
| Normalized Basic EPS | -27.99% | 66.25% | |||
| EPS Diluted | -28.03% | 65.70% | |||
| Normalized Diluted EPS | -27.99% | 66.25% | |||
| Average Basic Shares Outstanding | 23.79% | 55.08% | |||
| Average Diluted Shares Outstanding | 23.79% | 55.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||